These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1184 related articles for article (PubMed ID: 32989290)
1. Keeping track of the SARS-CoV-2 vaccine pipeline. Parker EPK; Shrotri M; Kampmann B Nat Rev Immunol; 2020 Nov; 20(11):650. PubMed ID: 32989290 [TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccine trials: Duty of care and standard of prevention considerations. Singh JA Vaccine; 2020 Nov; 38(48):7578-7580. PubMed ID: 33069443 [No Abstract] [Full Text] [Related]
3. The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Kochhar S; Excler JL; Kim D; Robertson JS; Fast PE; Condit RC; Drew S; Wood D; Gurwith M; Klug B; Whelan M; Khuri-Bulos N; Mallett Moore T; Smith ER; Chen RT; Vaccine; 2020 Sep; 38(39):6184-6189. PubMed ID: 32747214 [TBL] [Abstract][Full Text] [Related]
4. Exploring uncertainty and risk in the accelerated response to a COVID-19 vaccine: Perspective from the pharmaceutical industry. Coudeville L; Gomez GB; Jollivet O; Harris RC; Thommes E; Druelles S; Chit A; Chaves SS; Mahé C Vaccine; 2020 Nov; 38(48):7588-7595. PubMed ID: 33097312 [TBL] [Abstract][Full Text] [Related]
5. The Race to Develop a COVID-19 Vaccine. Am J Nurs; 2020 Oct; 120(10):14-15. PubMed ID: 32976132 [TBL] [Abstract][Full Text] [Related]
6. COVID-19: Small-Molecule Clinical Trials Landscape. Ferreira LLG; Andricopulo AD Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824 [No Abstract] [Full Text] [Related]
7. COVID-19 Vaccine: A comprehensive status report. Kaur SP; Gupta V Virus Res; 2020 Oct; 288():198114. PubMed ID: 32800805 [TBL] [Abstract][Full Text] [Related]
8. COVID-19 and Bacillus Calmette-Guérin: What is the Link? Hegarty PK; Sfakianos JP; Giannarini G; DiNardo AR; Kamat AM Eur Urol Oncol; 2020 Jun; 3(3):259-261. PubMed ID: 32327396 [TBL] [Abstract][Full Text] [Related]
9. All eyes on a hurdle race for a SARS-CoV-2 vaccine. Gaebler C; Nussenzweig MC Nature; 2020 Oct; 586(7830):501-502. PubMed ID: 33077943 [No Abstract] [Full Text] [Related]
10. Understanding COVID-19 vaccine efficacy. Lipsitch M; Dean NE Science; 2020 Nov; 370(6518):763-765. PubMed ID: 33087460 [No Abstract] [Full Text] [Related]
12. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time. Banerjee AK; Arora N Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303 [No Abstract] [Full Text] [Related]
13. Ensuring access and affordability through COVID-19 vaccine research and development investments: A proposal for the options market for vaccines. Forman R; Anderson M; Jit M; Mossialos E Vaccine; 2020 Sep; 38(39):6075-6077. PubMed ID: 32773244 [TBL] [Abstract][Full Text] [Related]
15. Dozens to be deliberately infected with coronavirus in UK 'human challenge' trials. Callaway E Nature; 2020 Oct; 586(7831):651-652. PubMed ID: 33082550 [No Abstract] [Full Text] [Related]
16. Developing Covid-19 Vaccines at Pandemic Speed. Lurie N; Saville M; Hatchett R; Halton J N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757 [No Abstract] [Full Text] [Related]
17. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related]
18. Prospect of SARS-CoV-2 spike protein: Potential role in vaccine and therapeutic development. Samrat SK; Tharappel AM; Li Z; Li H Virus Res; 2020 Oct; 288():198141. PubMed ID: 32846196 [TBL] [Abstract][Full Text] [Related]
19. Advances in skin science enable the development of a COVID-19 vaccine. Falo LD J Am Acad Dermatol; 2020 Oct; 83(4):1226-1227. PubMed ID: 32485211 [No Abstract] [Full Text] [Related]
20. Immunological considerations for COVID-19 vaccine strategies. Jeyanathan M; Afkhami S; Smaill F; Miller MS; Lichty BD; Xing Z Nat Rev Immunol; 2020 Oct; 20(10):615-632. PubMed ID: 32887954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]